Medical device company Merit Medical Systems (NASDAQ: MMSI) will be reporting earnings this Tuesday after market close. Here’s what to expect.
Merit Medical Systems beat analysts’ revenue expectations last quarter, reporting revenues of $384.2 million, up 13% year on year. It was a very strong quarter for the company, with a solid beat of analysts’ organic revenue estimates and an impressive beat of analysts’ revenue estimates.
Is Merit Medical Systems a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Merit Medical Systems’s revenue to grow 9.8% year on year, in line with the 9.4% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Merit Medical Systems has a history of exceeding Wall Street’s expectations.
Looking at Merit Medical Systems’s peers in the healthcare equipment and supplies segment, some have already reported their Q4 results, giving us a hint as to what we can expect. ICU Medical’s revenues decreased 13.8% year on year, beating analysts’ expectations by 1%, and Artivion reported revenues up 19.2%, falling short of estimates by 0.8%. ICU Medical traded up 4.9% following the results while Artivion was down 10%.
Read our full analysis of ICU Medical’s results here and Artivion’s results here.
The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.4% on average over the last month. Merit Medical Systems’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $103.64 (compared to the current share price of $82.21).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
